Last reviewed · How we verify
NCT03382275: EXPLAIN-IRON
EXPLorative Data Collection for Patient chAracterIzation, treatmeNt Pathways and Outcomes of IRON Preparations
trial testing Iron Supplement in Iron-deficiency in 51 participants. Completed in 20 April 2019.
20 April 2019
Quick facts
| Lead sponsor | GWT-TUD GmbH |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 51 |
| Start date | 16 January 2018 |
| Primary completion | 20 April 2019 |
| Estimated completion | 20 April 2019 |
| Sites | 2 locations across Germany |
Drugs / interventions tested
- Iron Supplement — full drug profile →
Conditions studied
- Iron-deficiency — all drugs for Iron-deficiency →
Sponsor
GWT-TUD GmbH — full company profile →
Who can join
Adults 18 to 99, any sex, with Iron-deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
By describing the characteristics of iron deficiency (ID) patients treated with various oral or intravenous iron formulations and their outcomes, this registry will provide the medical community with important information to support treatment decisions for their patients regarding data on effectiveness, safety, tolerability, treatment persistence, quality of life, and therapeutic costs. This will ultimately support improvements to patient care, including the long-term outcomes of patients with ID.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03382275
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Iron Supplement
Trials testing the same drug.
- NCT07095244 — Pediatric Outcomes and Recovery With Peri-Operative Iron Supplement Evaluation · NA · not yet recruiting
- NCT04014855 — Lactoferrin Versus Iron Supplement in Irondeficiency Anemia and Weight Loss in Obese Children · Phase 4 · completed
- NCT03542825 — Oral Lactoferrin Versus Iron Supplementation During Pregnancy · Phase 4 · completed
- NCT03112187 — FLIPS: Ferfer Liposomal Iron Performance Study · Phase 4 · completed
- NCT03171324 — to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Infants · Phase 4 · unknown
Other recruiting trials for Iron-deficiency
Currently open trials in the same condition.
- NCT05407987 — Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) · Phase 3 · recruiting
- NCT06270498 — Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure · Phase 4 · recruiting
- NCT05913414 — Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT05340465 — Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants · Phase 2 · recruiting
- NCT07083492 — Non-invasive Detection of Iron Deficiency in Obstetrics · recruiting
Other GWT-TUD GmbH trials
Trials by the same sponsor.
- NCT05181592 — Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome. · Phase 3 · active not recruiting
- NCT04833114 — Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line · Phase 3 · active not recruiting
- NCT04188639 — Emicizumab in Acquired Hemophilia A · Phase 2 · completed
- NCT04257448 — Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From · Phase 1, PHASE2 · completed
- NCT04121507 — ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03382275 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GWT-TUD GmbH
- Last refreshed: 2 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03382275.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing